A Study of NeoRecormon in Patients With Chronic Kidney Disease.

NCT00437723 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: epoetin beta [NeoRecormon]

Sponsor

Hoffmann-La Roche